Thanks to the extraordinary generosity of The Ralph M. Barford Foundation, the newly-established Elizabeth S. Barford Research Fund will provide an enhanced level of care to patients living with Late-Stage Multiple Sclerosis.
Canada has one of the highest rates of multiple sclerosis in the world, and it is the most common neurological disease affecting young adults in Canada. One in every 500 Canadians lives with MS and, every day, three more Canadians are diagnosed.
Toronto Rehab is filling the gap in services for the treatment of people with progressive stages of MS by pioneering a new model of therapy that incorporates a holistic approach to symptom management.
As the only MS-dedicated rehabilitation outpatient facility in Ontario, Toronto Rehab’s Rumsey Neuro Centre is providing specialized interdisciplinary care to people with demyelinating diseases of the brain, spinal cord and optic nerve. Comprehensive and integrated services provided at our clinic for 5,000 patient visits per year include: education and support; disease management; symptom management; rehabilitation and linkage to mental health services.
To continue to build on this expertise, The Elizabeth S. Barford Research Fund represents one of the largest and most transformative initiatives at the Toronto Rehabilitation Institute. The Ralph M. Barford Foundation’s generosity will allow Toronto Rehab to assemble a remarkable team to investigate and deliver the best treatments available to a unique patient population.
While the challenges faced by people living with MS, and those that care for them, are many, Toronto Rehab is making real headway in many areas of MS treatment; but the road ahead remains long. The transformational gift from the Ralph Barford Foundation will shape the way MS is managed across Canada, finding and implementing the most effective treatments and the most efficient methods to help the many Canadians living with Late-Stage MS.
In photo: Physiatrist Dr. Tania Bruno
at Toronto Rehab’s Rumsey Neuro site